Nyxoah to Release First Quarter 2022 Financial Results on May 9 and Host Conference Call on May 10, 2022

Nyxoah to Release First Quarter 2022 Financial Results on May 9 and Host Conference Call on May 10, 2022

Mont–Saint–Guibert, Belgium "" April 28, 2022, 10:30pm CET / 4:30pm ET "" Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)("Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter of 2022 on Monday, May 9, 2022, after the market close. Company management will host a conference call to discuss financial results on Tuesday, May 10, 2022, beginning at 2:00pm CET / 8:00am ET.

Investors interested in listening to the conference call may do so by dialing (844) 260–3718 for those in the U.S., 0800 73264 for those in Belgium, or (929) 517–0938 for international callers, followed by Conference ID 8444917. A live and archived webcast of the event will be available on the Company's investor relations website at https://investors.nyxoah.com.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah's lead solution is the Genio system, a patient–centered, leadless and battery–free hypoglossal neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors' therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/

Caution "" CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:
Nyxoah
Loic Moreau, Chief Financial Officer
corporate@nyxoah.com
+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com
+1 917 749 1494

Attachment


Bombardier to Report First Quarter 2022 Financial Results and Hold Virtual Annual and Special Meeting of Shareholders on Thursday, May 5, 2022

MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the first quarter of 2022 on May 5, 2022. On the same day, Bombardier will hold its Annual and Special Meeting of Shareholders ("Meeting") in a virtual format.

Quarterly Conference Call

On May 5, 2022, at 8:00 a.m. EDT, Bombardier will hold a webcast/conference call intended for investors and financial analysts to review the company's financial results for the first quarter ended March 31, 2022.

A live webcast of the call and relevant financial charts will be available at https://ir.bombardier.com

Stakeholders wishing to listen to the presentation and subsequent question–and–answer period by telephone may dial one of the following conference call numbers:

In English:

Toll–free dial–in number (Canada/U.S.): 1–800–898–3989
Local dial–in number: 514–861–3304
International dial–in numbers

Participant passcode: 2230833#

In French (with translation):
Toll–free dial–in number (Canada/U.S.): 1–877–395–0279
Local dial–in number: 514–392–1587
International dial–in numbers

Participant passcode: 4427560#

Media Call

May 5, 2022, at 9:30 a.m. EDT, members of the media are invited to dial in to a short Question and Answer session following our quarterly earnings call and before the virtual Annual and Special Meeting of Shareholders. ric Martel, President and Chief Executive Officer of Bombardier, will be available to answer your questions related to the Q1 2022 financial results.

Media who would like to attend the Q&A session are asked to RSVP by emailing heather.neale@aero.bombardier.com.

Bilingual:

Toll–free dial–in number (Canada/U.S.): 1–800–952–5114
Local dial–in number: 416–406–0743
International dial–in numbers

Participant passcode: 2423914#

Annual and Special Meeting of Shareholders

On May 5, 2022, at 10:30 a.m. EDT, Bombardier welcomes all registered shareholders and duly appointed proxyholders who wish to participate in the online Meeting to do so by joining the live webcast available at https://bombardier.com/en/agm2022. Only registered shareholders and duly appointed proxyholders will be allowed to vote and ask questions during the live Meeting. Non–registered shareholders, guests and media will be able to watch online via the live webcast available at the same link.

Instructions on how to vote and participate in the online Meeting, including submitting questions to management and to the Chairman of the Board of Directors of Bombardier, will be available on the Corporation's website here and on the online Meeting platform. Bombardier encourages shareholders to vote and submit their proxies prior to the Meeting.

The live webcast and relevant documents for both the Annual and Special Meeting of Shareholders and the conference call will be available at https://bombardier.com/en/agm2022. A recording of the Meeting and the call will be posted on Bombardier's website shortly after the end of the webcast.

About Bombardier
Bombardier is a global leader in aviation, focused on designing, manufacturing and servicing the world's most exceptional business jets. Bombardier's Challenger and Global aircraft families are renowned for their cutting–edge innovation, cabin design, performance and reliability. Bombardier has a worldwide fleet of approximately 5,000 aircraft in service with a wide variety of multinational corporations, charter and fractional ownership providers, governments and private individuals. Bombardier aircraft are also trusted around the world in special–mission roles.

Headquartered in Montral, Qubec, Bombardier operates aerostructure, assembly and completion facilities in Canada, the United States and Mexico. The company's robust customer support network includes facilities in strategic locations in the United States and Canada, as well as in the United Kingdom, Germany, France, Switzerland, Italy, Austria, the UAE, Singapore, China and an Australian facility opening in 2022.

For corporate news and information, including Bombardier's Environmental, Social and Governance report, visit bombardier.com. Learn more about Bombardier's industry–leading products and customer service network at businessaircraft.bombardier.com. Follow us on Twitter @Bombardier.

Bombardier is a registered trademark of Bombardier Inc. or its subsidiaries.

For Information

Francis Richer de La Flche
Vice President
Financial Planning and Investor Relations
Bombardier
+514 855 5001 x13228
Anna Cristofaro
Manager
Communications
Bombardier
+1 514 855 8678